Almost all cases of amyotrophic lateral sclerosis (ALS) and half of frontotemporal dementia (FTD) cases are linked to dysfunction in the protein TDP-43.
Eli Lilly has invested $700 million to launch a Boston, Mass., facility focusing on RNA-based therapeutics and genetic medicines.
Heidelberg-based Precisis GmbH has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its EASEE brain stimulator.
The cough medicine dextromethorphan has been shown to treat inherited heart arrhythmia disorders in mouse models and human cells.
We use cookies only to remember your preferences and provide better browsing experience. We do not sell user information. Here is our privacy policy.